Vadalà Giuseppe, Di Caccamo Leandro, Alaimo Chiara, Di Fazio Luca, Ferraiuoli Giovanni, Buccheri Giancarlo, Sucato Vincenzo, Galassi Alfredo Ruggero
Division of Cardiology, University Hospital Paolo Giaccone, Via del Vespro 129, 90100 Palermo, Italy.
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo, 90100 Palermo, Italy.
Diagnostics (Basel). 2022 Oct 19;12(10):2534. doi: 10.3390/diagnostics12102534.
Coronary artery aneurysm (CAA) is an abnormal dilatation of a coronary artery segment; those coronary artery aneurysms that are very large in size are defined as giant. However, a standardized dimension cut-off to define giant CAAs is still missing. The reported prevalence of coronary aneurysms in the population who underwent coronary angiography ranges from 0.3% to 5%, and often CAAs are found in patient with aneurysms in other sites, such as the ascending or abdominal aorta. In half of the cases an atherosclerotic etiology could be recognized; often, CAA is found in the context of acute coronary syndrome. Seldomly, CAA is found at the autopsy of patients who died due to sudden cardiac death. Currently, very few data exist about CAA management and their prognostic relevance; moreover, CAA treatment is still not clearly codified, but rather case-based. Indeed, currently there are no published dedicated studies exploring the best medical therapy, i.e., with antiplatelets or anticoagulant agents rather than an interventional approach such as an endovascular or surgical technique. In this review, through two clinical cases, the current evidence regarding diagnostic tools and treatment options of CAAs will be described.
冠状动脉瘤(CAA)是冠状动脉节段的异常扩张;那些尺寸非常大的冠状动脉瘤被定义为巨大冠状动脉瘤。然而,目前仍缺乏用于定义巨大冠状动脉瘤的标准化尺寸界限。在接受冠状动脉造影的人群中,报道的冠状动脉瘤患病率在0.3%至5%之间,并且冠状动脉瘤常出现在其他部位存在动脉瘤的患者中,如升主动脉或腹主动脉。在一半的病例中可识别出动脉粥样硬化病因;冠状动脉瘤常出现在急性冠状动脉综合征的背景下。很少在因心源性猝死死亡的患者尸检中发现冠状动脉瘤。目前,关于冠状动脉瘤的管理及其预后相关性的数据非常少;此外,冠状动脉瘤的治疗仍未明确规范,而是基于个案。事实上,目前尚无已发表的专门研究探讨最佳药物治疗,即使用抗血小板或抗凝药物而非诸如血管内或外科技术等介入方法。在本综述中,将通过两个临床病例描述目前关于冠状动脉瘤诊断工具和治疗选择的证据。